Docusign (NASDAQ:DOCU) Insider Sells $67,453.46 in Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 983 shares of the business’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $68.62, for a total value of $67,453.46. Following the completion of the transaction, the insider directly owned 70,179 shares in the company, valued at $4,815,682.98. This represents a 1.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Chatwani also recently made the following trade(s):

• On Wednesday, September 17th, Robert Chatwani sold 13,817 shares of Docusign stock. The stock was sold at an average price of $83.10, for a total value of $1,148,192.70.
• On Monday, September 15th, Robert Chatwani sold 1,682 shares of Docusign stock. The stock was sold at an average price of $80.30, for a total value of $135,064.60.

Docusign Stock Performance

Shares of DOCU opened at $71.11 on Monday. The firm has a market cap of $14.24 billion, a PE ratio of 49.73, a price-to-earnings-growth ratio of 3.57 and a beta of 0.98. Docusign Inc. has a 52-week low of $63.41 and a 52-week high of $99.71. The business’s 50 day moving average price is $69.18 and its two-hundred day moving average price is $74.52.

Analyst Ratings Changes

A number of equities research analysts have commented on DOCU shares. Wedbush reduced their price target on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Weiss Ratings restated a “hold (c)” rating on shares of Docusign in a research note on Wednesday, October 8th. Wall Street Zen raised Docusign from a “hold” rating to a “buy” rating in a research report on Saturday, September 13th. Argus reaffirmed a “hold” rating on shares of Docusign in a research note on Monday, September 8th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $95.00 price objective on shares of Docusign in a research note on Friday, December 5th. Four research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $86.71.

Hedge Funds Weigh In On Docusign

Hedge funds have recently added to or reduced their stakes in the stock. Banque Transatlantique SA purchased a new stake in shares of Docusign in the first quarter worth approximately $26,000. Summit Securities Group LLC bought a new stake in Docusign during the first quarter worth $34,000. Rise Advisors LLC grew its holdings in Docusign by 864.6% during the first quarter. Rise Advisors LLC now owns 463 shares of the company’s stock worth $38,000 after buying an additional 415 shares in the last quarter. WPG Advisers LLC purchased a new stake in Docusign in the 1st quarter valued at $39,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Docusign during the 2nd quarter valued at $43,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.